/saigenci/ en /saigenci/news/list/2025/12/18/meet-our-researchers-dr-adrienne-sullivan As Group Leader of the Development and Epigenetics Laboratory at SAiGENCI and the Adelaide Centre for Epigenetics, Dr Sullivan studies epigenetics, the molecular system that controls how genes are switched on and off without changing the DNA code itself. December 18 2025 a1095400 /saigenci/news/list/2025/12/18/meet-our-researchers-dr-adrienne-sullivan /saigenci/news/list/2025/12/18/fiona-hemstock-honouring-a-legacy-through-hope-and-discovery For SAiGENCI supporter Fiona Hemstock, giving is deeply personal — a way to honour a remarkable legacy while helping shape a future where cancer treatment is kinder, safer, and more effective. December 18 2025 a1095400 /saigenci/news/list/2025/12/18/fiona-hemstock-honouring-a-legacy-through-hope-and-discovery /saigenci/news/list/2025/12/18/a-gentler-future-for-radiation-treatment For many people facing cancer, radiation therapy is a vital part of their treatment.  But for most patients, it also brings an uncomfortable and sometimes painful side effect — skin damage caused by radiation. December 18 2025 a1095400 /saigenci/news/list/2025/12/18/a-gentler-future-for-radiation-treatment /saigenci/news/list/2025/12/16/switching-off-jumping-genes-to-outsmart-resistant-breast-cancer Breast cancer is the most commonly diagnosed cancer among women in Australia, with more than 21,000 new cases each year.  Around 70 per cent of these cancers are oestrogen receptor–positive (ER+), a type that often responds well to hormone-based treatments. December 16 2025 a1095400 /saigenci/news/list/2025/12/16/switching-off-jumping-genes-to-outsmart-resistant-breast-cancer /saigenci/news/list/2025/12/16/global-engagement-in-action-suzannes-research-exchange-sparks-future Suzanne Rajesh, a PhD student in the Prostate Cancer Research Group at the South Australian immunoGENomics Cancer Institute (SAiGENCI), is advancing the search for new biomarkers in prostate cancer through international collaboration. December 16 2025 a1095400 /saigenci/news/list/2025/12/16/global-engagement-in-action-suzannes-research-exchange-sparks-future /saigenci/news/list/2025/12/10/breakthroughs-in-ubiquitin-biology-highlighted-at-inaugural-australian The inaugural Lorne Ubiquitin Australian Ubiquitin Summit 2025, held from 16-20 of November in Lorne, Victoria, brought together leading scientists, clinicians, and industry innovators to explore one of the most dynamic areas of modern biomedical research:  ubiquitin biology and targeted protein degradation (TPD). December 10 2025 a1095400 /saigenci/news/list/2025/12/10/breakthroughs-in-ubiquitin-biology-highlighted-at-inaugural-australian /saigenci/news/list/2025/12/01/saigenci-welcomes-2025/26-summer-research-cohort SAiGENCI kicked off it’s 2025/26 summer research program with a morning tea last week, celebrating the arrival of this year’s students. December 1 2025 a1095400 /saigenci/news/list/2025/12/01/saigenci-welcomes-2025/26-summer-research-cohort /saigenci/news/list/2025/11/04/viertel-fellowship-for-innovative-cancer-epigentic-leader University of Adelaide cancer epigenetics and 3D genome biology expert Dr Joanna Achinger-Kawecka has been awarded a 2025 Sylvia and Charles Viertel Senior Medical Research Fellowship. November 4 2025 a1095400 /saigenci/news/list/2025/11/04/viertel-fellowship-for-innovative-cancer-epigentic-leader /saigenci/news/list/2025/11/12/professor-jose-polo-elected-fellow-of-the-australian-academy-of-health-and SAiGENCI are proud to announce Professor Jose Polo has been elected as Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).  October 30 2025 a1095400 /saigenci/news/list/2025/11/12/professor-jose-polo-elected-fellow-of-the-australian-academy-of-health-and /saigenci/news/list/2025/10/16/outcome-of-the-inaugural-professor-abdi-cancer-research-funding-initiative SAiGENCI is thrilled to share the exciting outcome of our inaugural Professor Abdi Cancer Research Funding Initiative.  This initiative is made possible by the generous donation from Professor Abdi, and the tremendous effort of everyone who have contributed to our philanthropic activities.  This round drew a large number of outstanding applications, making the selection process highly competitive. October 16 2025 a1095400 /saigenci/news/list/2025/10/16/outcome-of-the-inaugural-professor-abdi-cancer-research-funding-initiative